Cargando…
Cognitive and Adaptive Effects of Early Growth Hormone Treatment in Prader–Willi Syndrome Patients: A Cohort Study
Background: Prader–Willi Syndrome (PWS) is a genetically based neurodevelopmental disease characterized by obesity, hyperphagia, and mild to moderate intellectual disability. Treatment with growth hormone (GH) could provide cognitive benefits. The objective of the present study was to compare the co...
Autores principales: | Ayet-Roger, Aitana, Joga-Elvira, Lorena, Caixàs, Assumpta, Corripio, Raquel |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8955812/ https://www.ncbi.nlm.nih.gov/pubmed/35329918 http://dx.doi.org/10.3390/jcm11061592 |
Ejemplares similares
-
A Personalized Approach to Determining the Caloric Needs of Children with Prader–Willi Syndrome Treated with Growth Hormone
por: Couto-Rosende, Yolanda, et al.
Publicado: (2023) -
Growth Hormone (GH) Treatment Decreases Plasma Kisspeptin Levels in GH-Deficient Adults with Prader–Willi Syndrome
por: Giménez-Palop, Olga, et al.
Publicado: (2021) -
Gastric Dilatation and Abdominal Compartment Syndrome in a Child with Prader-Willi Syndrome
por: Blat, Clara, et al.
Publicado: (2017) -
Glucagon stimulation test to assess growth hormone status in Prader–Willi syndrome
por: Casamitjana, L., et al.
Publicado: (2020) -
Hunger and Satiety Peptides: Is There a Pattern to Classify Patients with Prader-Willi Syndrome?
por: Bueno, Marta, et al.
Publicado: (2021)